Comments: MD HB666 | 2017 | Regular Session

Bill Title: Public Health - Expensive Drugs - Manufacturer Reporting and Drug Price Transparency Advisory Committee

Spectrum: Partisan Bill (Democrat 74-0)

Status: (Introduced - Dead) 2017-02-23 - Hearing 2/23 at 1:00 p.m. [HB666 Detail]

Text: Latest bill text (Introduced) [PDF]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2017 Maryland HB666 at this time.

Social Comments on MD HB666

feedback